What's happening
This bill requires insurance policies in New York to cover additional breast cancer screenings, including advanced imaging, when recommended by providers following national guidelines.
Why it matters
Reduces out-of-pocket costs for patients. By prohibiting annual deductibles and coinsurance for additional breast cancer screenings, the bill removes significant financial barriers that might otherwise deter individuals from getting advanced imaging when needed.
Aligns coverage with evolving medical standards. The bill mandates insurance coverage for screenings and diagnostic imaging that follow "nationally recognized clinical practice guidelines," allowing for updates in medical best practices and ensuring patients receive care based on the latest evidence.
Expands the role of physician judgment. Coverage for advanced breast imaging (like ultrasounds and MRIs) is triggered by a provider’s recommendation in accordance with national guidelines, empowering providers to tailor screening to individual risk profiles rather than a one-size-fits-all approach.
Addresses gaps for high-risk and younger patients. By specifying coverage for patients with a personal or family history of breast cancer, and by including advanced imaging for those who need it, the bill improves early detection opportunities for populations that may not benefit from standard mammography alone.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients needing breast cancer imaging
The bill would require covered policies to cover physician-recommended screening and diagnostic imaging, including mammograms, ultrasounds and MRIs, recommended by nationally recognized clinical practice guidelines.
Health insurers and health service corporations
They would have to provide the added imaging coverage without annual deductibles or coinsurance, subject to a federal health savings account exception.
Physicians recommending breast imaging
Their recommendations, together with qualifying national clinical guidelines, would establish the basis for the added coverage requirement.
Enrollees in HSA-qualified high-deductible health plans
When necessary to preserve HSA eligibility under federal law, they would still have to meet the federal minimum deductible before the deductible waiver applies, except for qualifying preventive care.
Headline styles
Expand Breast Cancer Screenings
Plain English, a few words. Used as the page title.
Sponsors
History
- Substituted by A1696C
- Ordered to third reading cal.1633
- Committee discharged and committed to rules
- Print number 2465c
- Amend (t) and recommit to finance
- Print number 2465b
- Amend (t) and recommit to finance
- Print number 2465a
- Amend and recommit to finance
- Reported and committed to finance
- Referred to insurance
- Returned to senate
Show 8 earlier actions
- Died in assembly
- Referred to insurance
- Delivered to assembly
- Passed senateVote 62–0
- Ordered to third reading cal.1463
- Committee discharged and committed to rules
- Reported and committed to finance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Expand Breast Cancer Screenings
Signed by Governor · Sponsor Pamela J. Hunter
Full text
4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2465--C
2023-2024 Regular Sessions
IN SENATE
January 20, 2023
Introduced by Sens. PERSAUD, CHU, JACKSON, MYRIE, PALUMBO, SEPULVEDA -read twice and ordered printed, and when printed to be committed to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Senate Rule 6, sec. 8 --… Show allHide
Introduced by Sens. PERSAUD, CHU, JACKSON, MYRIE, PALUMBO, SEPULVEDA -read twice and ordered printed, and when printed to be committed to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee and committed to the Committee on Finance -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the insurance law, in relation to requiring certain insurance policies allow patients additional screenings for breast cancer when the provider deems such screening is necessary under nationally recognized clinical practice guidelines; and to repeal certain provisions of such law relating thereto
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subparagraphs (A) and (B) of paragraph 11 of subsection (i) of section 3216 of the insurance law, subparagraph (A) as amended by chapter 414 of the laws of 2017, and subparagraph (B) as amended by chapter 74 of the laws of 2016, are amended to read as follows:
(A) Every policy that provides coverage for hospital, surgical or medical care shall provide the following coverage for mammography screening for occult breast cancer:
(i) upon the recommendation of a physician, a mammogram, which may be provided by breast tomosynthesis, at any age for covered persons having a prior history of breast cancer or who have a first degree relative with a prior history of breast cancer;
(ii) a single baseline mammogram, which may be provided by breast tomosynthesis, for covered persons aged thirty-five through thirty-nine, inclusive; [and]
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02639-11-4
(iii) an annual mammogram, which may be provided by breast tomosynthesis, for covered persons aged forty and older; and
(iv) upon the recommendation of a physician, screening and diagnostic imaging, including diagnostic mammograms, breast ultrasounds, or magnetic resonance imaging, recommended by nationally recognized clinical practice guidelines for the detection of breast cancer. For the purposes of this item, "nationally recognized clinical practice guidelines" means evidence-based clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.
(B) Such coverage required pursuant to subparagraph (A) or (C) of this paragraph shall not be subject to annual deductibles or coinsurance. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
§ 2. Subparagraph (F) of paragraph 11 of subsection (i) of section 3216 of the insurance laws is REPEALED.
§ 3. Subparagraphs (A) and (B) of paragraph 11 of subsection (l) of section 3221 of the insurance law, subparagraph (A) as amended by chapter 143 of the laws of 2019, and subparagraph (B) as amended by chapter 74 of the laws of 2016, are amended to read as follows:
(A) Every insurer delivering a group or blanket policy or issuing a group or blanket policy for delivery in this state that provides coverage for hospital, surgical or medical care shall provide the following coverage for mammography screening for occult breast cancer:
(i) upon the recommendation of a physician, a mammogram, which may be provided by breast tomosynthesis, at any age for covered persons having a prior history of breast cancer or who have a first degree relative with a prior history of breast cancer;
(ii) a single baseline mammogram, which may be provided by breast tomosynthesis, for covered persons aged thirty-five through thirty-nine, inclusive;
(iii) an annual mammogram, which may be provided by breast tomosynthesis, for covered persons aged forty and older; [and]
(iv) for large group policies that provide coverage for hospital, surgical or medical care, an annual mammogram for covered persons aged thirty-five through thirty-nine, inclusive, upon the recommendation of a physician, subject to the insurer's determination that the mammogram is medically necessary; and
(v) upon the recommendation of a physician, screening and diagnostic imaging, including diagnostic mammograms, breast ultrasounds, or magnetic resonance imaging, recommended by nationally recognized clinical practice guidelines for the detection of breast cancer. For the purposes of this item, "nationally recognized clinical practice guidelines" means evidence-based clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.
(B) Such coverage required pursuant to subparagraph (A) or (C) of this paragraph shall not be subject to annual deductibles or coinsurance. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
§ 4. Subparagraph (F) of paragraph 11 of subsection (l) of section 3221 of the insurance law is REPEALED.
§ 5. Paragraph 1 of subsection (p) of section 4303 of the insurance law, as amended by chapter 219 of the laws of 2011, subparagraph (A) as amended by chapter 414 of the laws of 2017, and subparagraphs (B), (C), (D), and (E) as amended by chapter 143 of the laws of 2019, is amended to read as follows:
(1) A medical expense indemnity corporation, a hospital service corporation or a health service corporation that provides coverage for hospital, surgical or medical care shall provide the following coverage for mammography screening for occult breast cancer:
(A) upon the recommendation of a physician, a mammogram, which may be provided by breast tomosynthesis, at any age for covered persons having a prior history of breast cancer or who have a first degree relative with a prior history of breast cancer;
(B) a single baseline mammogram, which may be provided by breast tomosynthesis, for covered persons aged thirty-five through thirty-nine, inclusive;
(C) an annual mammogram, which may be provided by breast tomosythesis, for covered persons aged forty and older;
(D) for large group contracts offered by a medical expense indemnity corporation, a hospital service corporation or a health service corporation that provide coverage for hospital, surgical or medical care, an annual mammogram for covered persons aged thirty-five through thirtynine, inclusive, upon the recommendation of a physician, subject to the corporation's determination that the mammogram is medically necessary; [and]
(E) upon the recommendation of a physician, screening and diagnostic imaging, including diagnostic mammograms, breast ultrasounds, or magnetic resonance imaging, recommended by nationally recognized clinical practice guidelines for the detection of breast cancer. For the purposes of this subparagraph, "nationally recognized clinical practice guidelines" means evidence-based clinical practice guidelines informed by a systematic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy; and
(F) The coverage required in this paragraph or paragraph two of this subsection shall not be subject to annual deductibles or coinsurance. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.
§ 6. Paragraph 5 of subsection (p) of section 4303 of the insurance law is REPEALED.
§ 7. This act shall take effect January 1, 2026 and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to requiring certain insurance policies allow patients additional screenings for breast cancer when the provider deems such screening is necessary under nationally recognized clinical practice guidelines; and to repeal certain provisions of such law relating thereto
Purpose or general idea of bill
The purpose of this bill is to require commercial health insurance coverage of screening and diagnostic imaging, including diagnostic mammograms, breast ultrasounds, or magnetic resonance imaging, recom- mended by nationally recognized clinical practice guidelines for the detection of breast cancer.
Summary of specific provisions
Sections 1, and 3 of the bill requires individual, group, and Article 43 health insurance policies provide coverage of screening and diagnostic imaging, including diagnostic mammograms, breast ultrasounds, or magnet- ic resonance imaging, recommended by nationally recognized clinical practice guidelines for the detection of breast cancer. For the purposes of this legislation, nationally recognized clinical practice guidelines mean evidence-based clinical practice guidelines informed by a systemat- ic review of evidence and an assessment of the benefits, and risks of alternative care options intended to optimize patient care, developed by independent organizations or medical professional societies utilizing a transparent methodology and reporting structure and with a conflict of interest policy.
Sections 1, 3 and 5: Amends the bill to carve out insureds with high deductible health plans from cost sharing elimination if their HEMP deductibles are not met. This language would apply to all mammograms and the new covered services (ultrasound, diagnostic mammogram, and MRIs). However, because breast cancer screenings are considered preventive care by the IRS, HDHPs provide coverage for these services before the deduct- ible is met. Adding this language would protect insureds' HSA eligibil- ity in the event that these services are removed from the preventive care category by the IRS.
Sections 2, 4 and 6: Repeal language exempting ultrasounds, diagnostic mammogram, and MRIs from cost sharing. This bill adds these services to a subparagraph where coverage is already exempt from cost-sharing, making this old language unnecessary.
Section 7 of the bill sets the effective date.
Justification
Many individuals that identify as women end up with breast cancer despite completing a routine mammogram. Women in the United States have a higher breast cancer mortality rate than other cancers. A publication done by the University of Rochester Medical Center showed approximately 67 percent of women aged 40 and older receive a screening mammogram every one or two years. 16 percent of those screened will require addi- tional screening by their providers if it is their first mammogram, and 10 percent will be called to undergo further mammography exams.
In 2015, the American Association for Cancer Research reported that women who have a history of false-positives screening for mammogram exams or negative biopsies are at greater risk of getting breast cancer for at least a decade. False-positive mammogram screening helps provid- ers to detect early breast cancer. Allowing women to get an additional mammogram is an early intervention method that can save many lives, and this legislation aims to do just that.
Prior legislative history
2022: S8156 - Passed Senate
Fiscal implications
None.
Effective date
The act shall take effect on January 1, 2026.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.